Doug Schenkel
Stock Analyst
(n/a)
# 4,648
Out of 4,655 analysts
60
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Upgrades: Outperform | $285 | $247.76 | +15.03% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $59.29 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $136.87 | - | 8 | Jun 27, 2024 | |
| QGEN Qiagen | Upgrades: Outperform | $50 | $43.08 | +16.06% | 2 | Jun 27, 2024 | |
| TXG 10x Genomics | Downgrades: Peer Perform | n/a | $16.33 | - | 3 | Jun 27, 2024 | |
| ILMN Illumina | Initiates: Outperform | n/a | $149.76 | - | 5 | Dec 13, 2023 | |
| EXAS Exact Sciences | Initiates: Outperform | n/a | $69.80 | - | 4 | Dec 13, 2023 | |
| TMO Thermo Fisher | Initiates: Outperform | n/a | $557.92 | - | 3 | Dec 13, 2023 | |
| MYGN Myriad Genetics | Initiates: Outperform | n/a | $17.99 | - | 1 | Dec 13, 2023 | |
| RVTY Revvity | Initiates: Peer Perform | n/a | $121.04 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $2.44 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $22.31 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $23.00 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $124.16 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $387.21 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.64 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.92 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.81 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $13.46 | - | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.46 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.90 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.80 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $64 | $82.33 | -22.26% | 4 | Jun 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $41.57 | - | 1 | Nov 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $3.50 | +414.29% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $31.91 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $235.61 | -61.80% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $13.43 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $170.50 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $70.35 | -77.26% | 2 | Sep 28, 2017 |
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $247.76
Upside: +15.03%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $59.29
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $136.87
Upside: -
Qiagen
Jun 27, 2024
Upgrades: Outperform
Price Target: $50
Current: $43.08
Upside: +16.06%
10x Genomics
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $16.33
Upside: -
Illumina
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $149.76
Upside: -
Exact Sciences
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $69.80
Upside: -
Thermo Fisher
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $557.92
Upside: -
Myriad Genetics
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $17.99
Upside: -
Revvity
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $121.04
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $2.44
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $22.31
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $23.00
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $124.16
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $387.21
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.64
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.92
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.81
Upside: -
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $13.46
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.46
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.90
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.80
Upside: -
Jun 30, 2020
Upgrades: Outperform
Price Target: $64
Current: $82.33
Upside: -22.26%
Nov 26, 2018
Initiates: Outperform
Price Target: n/a
Current: $41.57
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $3.50
Upside: +414.29%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $31.91
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $235.61
Upside: -61.80%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $13.43
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $170.50
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $70.35
Upside: -77.26%